Patents by Inventor Arthur Kammeijer

Arthur Kammeijer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for scavenging radicals with urocanic acid, derivatives and analogues
    Patent number: 8026268
    Abstract: The invention relates to antioxidants or radical scavengers and their reaction products. The invention provides compounds and compositions for use in methods for scavenging radicals or for modulating the immune response comprising urocanic acid or salts, derivatives, functional equivalents and analogues thereof.
    Type: Grant
    Filed: November 29, 2005
    Date of Patent: September 27, 2011
    Assignee: Academisch Ziekenhuis bij de Universiteit van Amsterdam
    Inventors: Arthur Kammeijer, Joannes Dositheus Bos
  • UROCANIC ACID DERIVATIVES USEFUL FOR THE TREATMENT OF IMMUNE-RELATED AND INFLAMMATORY DISEASES
    Publication number: 20100197752
    Abstract: The invention relates to derivatives of urocanic acid that have improved efficacy and/or tissue penetration properties. The invention further provides use of these derivatives in a medicament for modulating an immune-related disease in an individual.
    Type: Application
    Filed: June 11, 2008
    Publication date: August 5, 2010
    Inventor: Arthur Kammeijer
  • Method for scavenging radicals with urocanic acid, derivatives and analogues
    Patent number: 7056938
    Abstract: Upon exposure to UVB, the epidermal component trans-urocanic acid is not only photoisomerized into cis-urocanic acid, but will also, at least in part, be photooxidized into urocanic acid oxidation products. We hypothesized that urocanic acid oxidation products can mimic UV-induced systemic immunosuppression comparable to the suppressive properties already established for cis-urocanic acid. A crude mixture of urocanic acid oxidation products showed a significant suppression of the sensitization phase of the systemic contact hypersensitivity response to picryl chloride. Three of the urocanic acid oxidation products were selected for this study: imidazole-4-carboxylic acid, imidazole-4-carboxaldehyde and imidazole-4-acetic acid. Effects on the sensitization-, elicitation- and post-elicitation phase of contact hypersensitivity to picryl chloride in BALB/c mice were studied and compared to the effects of cis-urocanic acid.
    Type: Grant
    Filed: June 23, 2000
    Date of Patent: June 6, 2006
    Assignee: Academisch Ziekenhuis Bij De Univ.
    Inventors: Arthur Kammeijer, Joannes Dositheus Bos
  • Method for scavenging radicals with urocanic acid, derivatives and analogues
    Publication number: 20060106108
    Abstract: The invention relates to antioxidants or radical scavengers and their reaction products. The invention provides compounds and compositions for use in methods for scavenging radicals or for modulating the immune response comprising urocanic acid or salts, derivatives, functional equivalents and analogues thereof.
    Type: Application
    Filed: November 29, 2005
    Publication date: May 18, 2006
    Inventors: Arthur Kammeijer, Joannes Bos